Skip to main content

Table 1 Immunohistochemical analysis of MEKK3 protein in esophageal tissues and relationship with clinicopathological parameters

From: Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis

Clinicopathological features

Total cases (N)

Cytoplasmic/nuclear positivity n (%)

P-value

OR (95% CI)

Normal

47

10 (21)

  

Dysplasia

61

34 (55.7)

<0.001

4.6 (1.9-11.0)

ESCC

93

63 (67.7)

0.001

7.77 (3.41-17.7)

Age (years)

    

<54

43

30 (69.8)

0.825

0.84 (0.35-2.01)

> = 54

50

33 (66)

  

Gender

    

Male

62

40 (64.5)

0.481

1.58 (0.60-4.12)

Female

31

23 (74.2)

  

Tumor stage

    

(T1 + T2)

10

6 (60.0)

0.722

1.46 (0.38-5.62)

(T3 + T4)

83

57 (68.7)

  

Nodal status

    

N0

27

19 (70.4)

0.81

0.84 (0.31-2.22)

N1

66

44 (66.7)

  

Histopathology

    

WDSCC

30

20 (66.7)

0.61

0.6 (0.20-1.87)

MDSCC

48

33 (68.7)

  

PDSCC

15

10 (66.7)